Toni Shippenberg, Ph.D. - Publications

Affiliations: 
National Institute on Drug Abuse 
Area:
Drug addiction

108 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Sundaramurthy S, Annamalai B, Samuvel DJ, Shippenberg TS, Jayanthi LD, Ramamoorthy S. Modulation of serotonin transporter function by kappa-opioid receptor ligands. Neuropharmacology. PMID 27743931 DOI: 10.1016/J.Neuropharm.2016.10.011  0.323
2014 Kivell B, Uzelac Z, Sundaramurthy S, Rajamanickam J, Ewald A, Chefer V, Jaligam V, Bolan E, Simonson B, Annamalai B, Mannangatti P, Prisinzano TE, Gomes I, Devi LA, Jayanthi LD, ... ... Shippenberg TS, et al. Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism. Neuropharmacology. 86: 228-40. PMID 25107591 DOI: 10.1016/J.Neuropharm.2014.07.016  0.768
2013 Kuzmin A, Chefer V, Bazov I, Meis J, Ögren SO, Shippenberg T, Bakalkin G. Upregulated dynorphin opioid peptides mediate alcohol-induced learning and memory impairment. Translational Psychiatry. 3: e310. PMID 24105441 DOI: 10.1038/Tp.2013.72  0.344
2013 Chefer VI, Bäckman CM, Gigante ED, Shippenberg TS. Kappa opioid receptors on dopaminergic neurons are necessary for kappa-mediated place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2623-31. PMID 23921954 DOI: 10.1038/Npp.2013.171  0.357
2013 Tejeda HA, Counotte DS, Oh E, Ramamoorthy S, Schultz-Kuszak KN, Bäckman CM, Chefer V, O'Donnell P, Shippenberg TS. Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1770-9. PMID 23542927 DOI: 10.1038/Npp.2013.76  0.755
2012 Tejeda HA, Shippenberg TS, Henriksson R. The dynorphin/κ-opioid receptor system and its role in psychiatric disorders. Cellular and Molecular Life Sciences : Cmls. 69: 857-96. PMID 22002579 DOI: 10.1007/s00018-011-0844-x  0.694
2011 Chefer V, Meis J, Wang G, Kuzmin A, Bakalkin G, Shippenberg T. Repeated exposure to moderate doses of ethanol augments hippocampal glutamate neurotransmission by increasing release. Addiction Biology. 16: 229-37. PMID 21182572 DOI: 10.1111/J.1369-1600.2010.00272.X  0.31
2010 Tejeda HA, Chefer VI, Zapata A, Shippenberg TS. The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat. Psychopharmacology. 210: 231-40. PMID 20232058 DOI: 10.1007/s00213-010-1799-6  0.711
2009 Chefer VI, Denoroy L, Zapata A, Shippenberg TS. Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms. The European Journal of Neuroscience. 30: 272-8. PMID 19614973 DOI: 10.1111/j.1460-9568.2009.06827.x  0.347
2009 Shippenberg TS, Chefer VI, Thompson AC. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biological Psychiatry. 65: 169-74. PMID 18950747 DOI: 10.1016/j.biopsych.2008.09.009  0.355
2009 Chefer VI, Shippenberg TS. Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 887-98. PMID 18704097 DOI: 10.1038/Npp.2008.128  0.469
2008 Shippenberg TS, LeFevour A, Chefer VI. Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction. Cns & Neurological Disorders Drug Targets. 7: 442-53. PMID 19128202 DOI: 10.2174/187152708786927813  0.349
2008 Gehrke BJ, Chefer VI, Shippenberg TS. Effects of acute and repeated administration of salvinorin A on dopamine function in the rat dorsal striatum. Psychopharmacology. 197: 509-17. PMID 18246329 DOI: 10.1007/s00213-007-1067-6  0.375
2008 Jackson SN, Singhal SK, Woods AS, Morales M, Shippenberg T, Zhang L, Oz M. Volatile anesthetics and endogenous cannabinoid anandamide have additive and independent inhibitory effects on alpha(7)-nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. European Journal of Pharmacology. 582: 42-51. PMID 18242598 DOI: 10.1016/J.Ejphar.2007.12.023  0.301
2008 Butt C, Alptekin A, Shippenberg T, Oz M. Endogenous cannabinoid anandamide inhibits nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Journal of Neurochemistry. 105: 1235-43. PMID 18194436 DOI: 10.1111/J.1471-4159.2008.05225.X  0.336
2008 Chandran JS, Lin X, Zapata A, Höke A, Shimoji M, Moore SO, Galloway MP, Laird FM, Wong PC, Price DL, Bailey KR, Crawley JN, Shippenberg T, Cai H. Progressive behavioral deficits in DJ-1-deficient mice are associated with normal nigrostriatal function. Neurobiology of Disease. 29: 505-14. PMID 18187333 DOI: 10.1016/J.Nbd.2007.11.011  0.343
2008 Schepers RJ, Mahoney JL, Shippenberg TS. Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception. Pain. 136: 320-30. PMID 17764840 DOI: 10.1016/j.pain.2007.07.010  0.381
2007 Zapata A, Kivell B, Han Y, Javitch JA, Bolan EA, Kuraguntla D, Jaligam V, Oz M, Jayanthi LD, Samuvel DJ, Ramamoorthy S, Shippenberg TS. Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors. The Journal of Biological Chemistry. 282: 35842-54. PMID 17923483 DOI: 10.1074/Jbc.M611758200  0.74
2007 Bolan EA, Kivell B, Jaligam V, Oz M, Jayanthi LD, Han Y, Sen N, Urizar E, Gomes I, Devi LA, Ramamoorthy S, Javitch JA, Zapata A, Shippenberg TS. D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism. Molecular Pharmacology. 71: 1222-32. PMID 17267664 DOI: 10.1124/Mol.106.027763  0.742
2007 Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A, Shippenberg T, Wang JB. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 1774-82. PMID 17203012 DOI: 10.1038/Sj.Npp.1301301  0.383
2006 Doyon WM, Howard EC, Shippenberg TS, Gonzales RA. Kappa-opioid receptor modulation of accumbal dopamine concentration during operant ethanol self-administration. Neuropharmacology. 51: 487-96. PMID 16781738 DOI: 10.1016/J.Neuropharm.2006.04.005  0.333
2006 Margolis EB, Lock H, Chefer VI, Shippenberg TS, Hjelmstad GO, Fields HL. Kappa opioids selectively control dopaminergic neurons projecting to the prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America. 103: 2938-42. PMID 16477003 DOI: 10.1073/pnas.0511159103  0.351
2006 Chefer VI, Zapata A, Shippenberg TS, Bungay PM. Quantitative no-net-flux microdialysis permits detection of increases and decreases in dopamine uptake in mouse nucleus accumbens. Journal of Neuroscience Methods. 155: 187-93. PMID 16466808 DOI: 10.1016/j.jneumeth.2005.12.018  0.365
2006 Chefer VI, Shippenberg TS. Paradoxical effects of prodynorphin gene deletion on basal and cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens. The European Journal of Neuroscience. 23: 229-38. PMID 16420432 DOI: 10.1111/j.1460-9568.2005.04525.x  0.38
2005 Chefer VI, Czyzyk T, Bolan EA, Moron J, Pintar JE, Shippenberg TS. Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 5029-37. PMID 15901784 DOI: 10.1523/Jneurosci.0854-05.2005  0.738
2005 Zapata A, Shippenberg TS. Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels. Neuropharmacology. 48: 43-50. PMID 15617726 DOI: 10.1016/j.neuropharm.2004.09.003  0.32
2005 Hauser KF, Aldrich JV, Anderson KJ, Bakalkin G, Christie MJ, Hall ED, Knapp PE, Scheff SW, Singh IN, Vissel B, Woods AS, Yakovleva T, Shippenberg TS. Pathobiology of dynorphins in trauma and disease. Frontiers in Bioscience : a Journal and Virtual Library. 10: 216-35. PMID 15574363 DOI: 10.2741/1522  0.333
2004 Chefer VI, Kieffer BL, Shippenberg TS. Contrasting effects of mu opioid receptor and delta opioid receptor deletion upon the behavioral and neurochemical effects of cocaine. Neuroscience. 127: 497-503. PMID 15262338 DOI: 10.1016/J.Neuroscience.2004.05.021  0.345
2004 Oz M, Woods AS, Shippenberg T, Kaminski RM. Effects of extracellular pH on the dynorphin A inhibition of N-methyl-D-aspartate receptors expressed in Xenopus oocytes. Synapse (New York, N.Y.). 52: 84-8. PMID 15034914 DOI: 10.1002/Syn.20009  0.34
2004 Oz M, Zakharova I, Dinc M, Shippenberg T. Cocaine inhibits cromakalim-activated K+ currents in follicle-enclosed Xenopus oocytes. Naunyn-Schmiedeberg's Archives of Pharmacology. 369: 252-9. PMID 14652711 DOI: 10.1007/S00210-003-0838-9  0.302
2003 Chefer VI, Kieffer BL, Shippenberg TS. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. The European Journal of Neuroscience. 18: 1915-22. PMID 14622224 DOI: 10.1046/J.1460-9568.2003.02912.X  0.377
2002 Witkin JM, Gasior M, Schad C, Zapata A, Shippenberg T, Hartman T, Slusher BS. NAALADase (GCP II) inhibition prevents cocaine-kindled seizures. Neuropharmacology. 43: 348-56. PMID 12243764 DOI: 10.1016/S0028-3908(02)00124-7  0.314
2002 Basile AS, Fedorova I, Zapata A, Liu X, Shippenberg T, Duttaroy A, Yamada M, Wess J. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America. 99: 11452-7. PMID 12154229 DOI: 10.1073/Pnas.162371899  0.416
2002 Chefer VI, Shippenberg TS. Changes in basal and cocaine-evoked extracellular dopamine uptake and release in the rat nucleus accumbens during early abstinence from cocaine: quantitative determination under transient conditions. Neuroscience. 112: 907-19. PMID 12088750 DOI: 10.1016/S0306-4522(02)00099-4  0.315
2002 Zapata A, Shippenberg TS. D(3) receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens. Journal of Neurochemistry. 81: 1035-42. PMID 12065616 DOI: 10.1046/j.1471-4159.2002.00893.x  0.355
2001 Zapata A, Witkin JM, Shippenberg TS. Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacology. 41: 351-9. PMID 11522326 DOI: 10.1016/S0028-3908(01)00069-7  0.34
2001 Shippenberg TS, Chefer VI, Zapata A, Heidbreder CA. Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Annals of the New York Academy of Sciences. 937: 50-73. PMID 11458540 DOI: 10.1111/j.1749-6632.2001.tb03558.x  0.314
2001 He M, Sibille E, Benjamin D, Toth M, Shippenberg T. Differential effects of 5-HT1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Research. 902: 11-7. PMID 11376590 DOI: 10.1016/S0006-8993(01)02271-5  0.304
2001 Acri JB, Thompson AC, Shippenberg T. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593. Synapse (New York, N.Y.). 39: 343-50. PMID 11169785 DOI: 10.1002/1098-2396(20010315)39:4<343::Aid-Syn1018>3.0.Co;2-Q  0.56
2000 Thompson AC, Zapata A, Justice JB, Vaughan RA, Sharpe LG, Shippenberg TS. Kappa-opioid receptor activation modifies dopamine uptake in the nucleus accumbens and opposes the effects of cocaine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 9333-40. PMID 11125013  0.432
2000 Chefer VI, Morón JA, Hope B, Rea W, Shippenberg TS. Kappa-opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine. Neuroscience. 101: 619-27. PMID 11113311 DOI: 10.1016/S0306-4522(00)00417-6  0.347
2000 Shippenberg TS, Funada M, Schutz CG. Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat. Psychopharmacology. 151: 351-8. PMID 11026742 DOI: 10.1007/s002130000475  0.337
2000 Schenk S, Partridge B, Shippenberg TS. Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593. Psychopharmacology. 151: 85-90. PMID 10958121 DOI: 10.1007/S002130000476  0.324
2000 Sharpe LG, Pilotte NS, Shippenberg TS, Goodman CB, London ED. Autoradiographic evidence that prolonged withdrawal from intermittent cocaine reduces mu-opioid receptor expression in limbic regions of the rat brain. Synapse (New York, N.Y.). 37: 292-7. PMID 10891866 DOI: 10.1002/1098-2396(20000915)37:4<292::AID-SYN6>3.0.CO;2-V  0.34
2000 Shippenberg TS, Hen R, He M. Region-specific enhancement of basal extracellular and cocaine-evoked dopamine levels following constitutive deletion of the Serotonin(1B) receptor. Journal of Neurochemistry. 75: 258-65. PMID 10854269 DOI: 10.1046/j.1471-4159.2000.0750258.x  0.342
2000 El Daly E, Chefer V, Sandill S, Shippenberg TS. Modulation of the neurotoxic effects of methamphetamine by the selective kappa-opioid receptor agonist U69593. Journal of Neurochemistry. 74: 1553-62. PMID 10737612 DOI: 10.1046/j.1471-4159.2000.0741553.x  0.449
1999 Gray AM, Rawls SM, Shippenberg TS, McGinty JF. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. Journal of Neurochemistry. 73: 1066-74. PMID 10461896 DOI: 10.1046/j.1471-4159.1999.0731066.x  0.373
1999 Chen L, He M, Sibille E, Thompson A, Sarnyai Z, Baker H, Shippenberg T, Toth M. Adaptive changes in postsynaptic dopamine receptors despite unaltered dopamine dynamics in mice lacking monoamine oxidase B. Journal of Neurochemistry. 73: 647-55. PMID 10428061 DOI: 10.1046/J.1471-4159.1999.0730647.X  0.428
1999 Chefer V, Thompson AC, Shippenberg TS. Modulation of cocaine-induced sensitization by kappa-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex. Annals of the New York Academy of Sciences. 877: 803-6. PMID 10415709 DOI: 10.1111/j.1749-6632.1999.tb09327.x  0.349
1999 Witkin JM, Savtchenko N, Mashkovsky M, Beekman M, Munzar P, Gasior M, Goldberg SR, Ungard JT, Kim J, Shippenberg T, Chefer V. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 288: 1298-310. PMID 10027871  0.311
1998 Izenwasser S, Acri JB, Kunko PM, Shippenberg T. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors. Synapse (New York, N.Y.). 30: 275-83. PMID 9776131 DOI: 10.1002/(Sici)1098-2396(199811)30:3<275::Aid-Syn5>3.0.Co;2-8  0.499
1998 Heidbreder CA, Schenk S, Partridge B, Shippenberg TS. Increased responsiveness of mesolimbic and mesostriatal dopamine neurons to cocaine following repeated administration of a selective kappa-opioid receptor agonist. Synapse (New York, N.Y.). 30: 255-62. PMID 9776129 DOI: 10.1002/(Sici)1098-2396(199811)30:3<255::Aid-Syn3>3.0.Co;2-A  0.359
1998 De Vries TJ, Cools AR, Shippenberg TS. Infusion of a D-1 receptor agonist into the nucleus accumbens enhances cocaine-induced behavioural sensitization. Neuroreport. 9: 1763-8. PMID 9665597  0.339
1998 Shippenberg TS, LeFevour A, Thompson AC. Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the kappa-opioid receptor agonist U69593. European Journal of Pharmacology. 345: 27-34. PMID 9593590 DOI: 10.1016/S0014-2999(97)01614-2  0.327
1997 Shippenberg TS, Rea W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa-opioid receptor agonists. Pharmacology, Biochemistry, and Behavior. 57: 449-55. PMID 9218269 DOI: 10.1016/S0091-3057(96)00450-9  0.42
1996 Funada M, Shippenberg TS. Differential involvement of D1 and D2 dopamine receptors in the expression of morphine withdrawal signs in rats. Behavioural Pharmacology. 7: 448-453. PMID 11224440  0.419
1996 Shippenberg TS, Heidbreder C, Lefevour A. Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics. European Journal of Pharmacology. 299: 33-9. PMID 8901005 DOI: 10.1016/0014-2999(95)00852-7  0.31
1996 Funada M, Schutz CG, Shippenberg TS. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat. European Journal of Pharmacology. 300: 17-24. PMID 8741160 DOI: 10.1016/0014-2999(95)00860-8  0.391
1996 Shippenberg TS, LeFevour A, Heidbreder C. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. The Journal of Pharmacology and Experimental Therapeutics. 276: 545-54. PMID 8632320  0.326
1995 Shippenberg TS, Bals-Kubik R. Involvement of the mesolimbic dopamine system in mediating the aversive effects of opioid antagonists in the rat. Behavioural Pharmacology. 6: 99-106. PMID 11224316  0.452
1995 de Vries TJ, Babovic-Vuksanovic D, Elmer G, Shippenberg TS. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology. 120: 442-8. PMID 8539325 DOI: 10.1007/BF02245816  0.323
1995 Shoaib M, Spanagel R, Stohr T, Shippenberg TS. Strain differences in the rewarding and dopamine-releasing effects of morphine in rats. Psychopharmacology. 117: 240-7. PMID 7753973 DOI: 10.1007/Bf02245193  0.302
1995 Shippenberg TS, Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. European Journal of Pharmacology. 280: 55-61. PMID 7498254 DOI: 10.1016/0014-2999(95)00185-N  0.31
1994 Spanagel R, Almeida OF, Bartl C, Shippenberg TS. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology. 115: 121-7. PMID 7862883 DOI: 10.1007/Bf02244761  0.403
1994 Spanagel R, Almeida OF, Shippenberg TS. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes. European Journal of Pharmacology. 264: 157-62. PMID 7851478 DOI: 10.1016/0014-2999(94)00449-8  0.392
1994 Shippenberg T, Heidbreder C. Role of kappa and delta opioid systems in modulating sensitization to the rewarding effects of cocaine Regulatory Peptides. 54: 273-274. DOI: 10.1016/0167-0115(94)90495-2  0.424
1993 Heidbreder CA, Goldberg SR, Shippenberg TS. The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Research. 616: 335-8. PMID 8395306 DOI: 10.1016/0006-8993(93)90228-F  0.353
1993 Spanagel R, Shippenberg TS. Modulation of morphine-induced sensitization by endogenous kappa opioid systems in the rat. Neuroscience Letters. 153: 232-6. PMID 8392157 DOI: 10.1016/0304-3940(93)90329-J  0.377
1993 Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. The Journal of Pharmacology and Experimental Therapeutics. 265: 53-9. PMID 8386244  0.475
1993 Heidbreder C, Goldberg SR, Shippenberg TS. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. European Journal of Pharmacology. 243: 123-7. PMID 8276060 DOI: 10.1016/0014-2999(93)90370-W  0.34
1993 Spanagel R, Almeida OF, Shippenberg TS. Long lasting changes in morphine-induced mesolimbic dopamine release after chronic morphine exposure. Synapse (New York, N.Y.). 14: 243-5. PMID 8211708 DOI: 10.1002/Syn.890140307  0.328
1993 Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. The Journal of Pharmacology and Experimental Therapeutics. 264: 489-95. PMID 8093731  0.414
1993 Spanagel R, Herz A, Shippenberg TS. Dopamine release in the mesolimbic system is modulated by opposing endogenous opioid systems Nida Research Monograph Series. 109.  0.37
1992 Ayesta FJ, Ableitner A, Emmett-Oglesby MW, Herz A, Shippenberg TS. Paradoxical effect of chronic fentanyl treatment on naltrexone-induced supersensitivity and upregulation. The Journal of Pharmacology and Experimental Therapeutics. 260: 168-74. PMID 1731036  0.373
1992 Herz A, Shippenberg TS, Bals-Kubik R, Spanagel R. [Opiate addiction. Pharmacologic and biochemical aspects]. Arzneimittel-Forschung. 42: 256-9. PMID 1586396  0.47
1992 Spanagel R, Herz A, Shippenberg TS. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the United States of America. 89: 2046-50. PMID 1347943 DOI: 10.1073/Pnas.89.6.2046  0.446
1992 Shippenberg TS, Herz A, Spanagel R, Bals-Kubik R, Stein C. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Annals of the New York Academy of Sciences. 654: 347-56. PMID 1321576 DOI: 10.1111/J.1749-6632.1992.Tb25980.X  0.51
1991 Spanagel R, Herz A, Bals-Kubik R, Shippenberg TS. Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens. Psychopharmacology. 104: 51-6. PMID 1882003 DOI: 10.1007/Bf02244553  0.504
1991 Shippenberg TS, Herz A. Influence of chronic lithium treatment upon the motivational effects of opioids: alteration in the effects of mu- but not kappa-opioid receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 256: 1101-6. PMID 1848627  0.587
1991 Shippenberg TS, Bals-Kubik R, Huber A, Herz A. Neuroanatomical substrates mediating the aversive effects of D-1 dopamine receptor antagonists. Psychopharmacology. 103: 209-14. PMID 1827526 DOI: 10.1007/BF02244205  0.567
1991 Shippenberg TS. Conditioned reinforcing effects of 8-hydroxy-2-(di-N-propylamino) tetralin: involvement of 5-hydroxytryptamine 1A and D1 dopamine receptors. Neuroscience Letters. 121: 136-8. PMID 1826942 DOI: 10.1016/0304-3940(91)90668-J  0.382
1991 Spanagel R, Herz A, Shippenberg TS. Modulation of the mesolimbic dopaminergic system by beta-endorphin-(1-27) as assessed by microdialysis. European Journal of Pharmacology. 200: 319-24. PMID 1782993 DOI: 10.1016/0014-2999(91)90589-I  0.451
1991 Shippenberg TS, Herz A, Nikolarakis K. Prolonged inflammatory pain modifies corticotropin-releasing factor-induced opioid peptide release in the hypothalamus. Brain Research. 563: 209-14. PMID 1686211 DOI: 10.1016/0006-8993(91)91535-9  0.49
1990 Spanagel R, Herz A, Shippenberg TS. Identification of the opioid receptor types mediating beta-endorphin-induced alterations in dopamine release in the nucleus accumbens. European Journal of Pharmacology. 190: 177-84. PMID 1981749 DOI: 10.1016/0014-2999(90)94124-G  0.571
1990 Spanagel R, Herz A, Shippenberg TS. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. Journal of Neurochemistry. 55: 1734-40. PMID 1976759 DOI: 10.1111/J.1471-4159.1990.Tb04963.X  0.608
1990 Bals-Kubik R, Shippenberg TS, Herz A. Involvement of central mu and delta opioid receptors in mediating the reinforcing effects of beta-endorphin in the rat. European Journal of Pharmacology. 175: 63-9. PMID 1969799 DOI: 10.1016/0014-2999(90)90153-w  0.549
1990 Herz A, Bals-Kubik R, Spanagel R, Shippenberg T. Neurochemical aspects of opioid addiction European Journal of Pharmacology. 183: 140. DOI: 10.1016/0014-2999(90)91408-4  0.576
1990 Herz A, Bals-Kubik R, Spanagel R, Shippenberg T. Neurochemical aspects of opioid addiction European Journal of Pharmacology. 183: 140.  0.326
1990 Bals-Kubik R, Shippenberg TS, Herz A. Neuroanatomical substrates mediating the motivational effects of opioids New Leads in Opioid Research: Proceedings of the International Narcotics Research Conference. Ics914. 11.  0.327
1989 Emmett-Oglesby MW, Shippenberg TS, Herz A. Fentanyl and morphine discrimination in rats continuously infused with fentanyl. Behavioural Pharmacology. 1: 3-11. PMID 11175382 DOI: 10.1097/00008877-198900110-00002  0.477
1989 Shippenberg TS, Emmett-Oglesby MW, Herz A. Morphine-induced place conditioning is not confounded by drug-induced alterations in locomotor activity. Pharmacology, Biochemistry, and Behavior. 32: 129-32. PMID 2734325 DOI: 10.1016/0091-3057(89)90221-9  0.309
1989 Bals-Kubik R, Herz A, Shippenberg TS. Evidence that the aversive effects of opioid antagonists and kappa-agonists are centrally mediated. Psychopharmacology. 98: 203-6. PMID 2569217 DOI: 10.1007/BF00444692  0.584
1989 Stein C, Millan MJ, Shippenberg TS, Peter K, Herz A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. The Journal of Pharmacology and Experimental Therapeutics. 248: 1269-75. PMID 2539460  0.396
1988 Stein C, Millan MJ, Shippenberg TS, Herz A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neuroscience Letters. 84: 225-8. PMID 3340329 DOI: 10.1016/0304-3940(88)90412-0  0.494
1988 Shippenberg TS, Emmett-Oglesby MW, Ayesta FJ, Herz A. Tolerance and selective cross-tolerance to the motivational effects of opioids. Psychopharmacology. 96: 110-5. PMID 3147470 DOI: 10.1007/BF02431542  0.559
1988 Bals-Kubik R, Herz A, Shippenberg TS. Beta-endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Archives of Pharmacology. 338: 392-6. PMID 2854207 DOI: 10.1007/BF00172115  0.523
1988 Shippenberg TS, Stein C, Huber A, Millan MJ, Herz A. Motivational effects of opioids in an animal model of prolonged inflammatory pain: alteration in the effects of kappa- but not of mu-receptor agonists. Pain. 35: 179-86. PMID 2853321 DOI: 10.1016/0304-3959(88)90225-4  0.381
1988 Shippenberg TS, Millan MJ, Mucha RF, Herz A. Involvement of beta-endorphin and mu-opioid receptors in mediating the aversive effect of lithium in the rat. European Journal of Pharmacology. 154: 135-44. PMID 2852596 DOI: 10.1016/0014-2999(88)90090-8  0.553
1988 Shippenberg TS, Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. European Journal of Pharmacology. 151: 233-42. PMID 2844553 DOI: 10.1016/0014-2999(88)90803-5  0.596
1988 Shippenberg T, Bals-Kubik R, Herz A. Endogenous opioids and reinforcement: Role of multiple opioid receptor types and dopamine Nida Research Monograph Series. 40.  0.417
1987 Shippenberg TS, Herz A. Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of mu- and kappa-opioid agonists. Brain Research. 436: 169-72. PMID 2961413 DOI: 10.1016/0006-8993(87)91571-X  0.606
1987 Shippenberg T, Herz A. Motivational properties of opioids. Polish Journal of Pharmacology and Pharmacy. 39: 577-83. PMID 2852365  0.551
1987 Shippenberg TS, Bals-Kubik R, Herz A. Motivational properties of opioids: evidence that an activation of delta-receptors mediates reinforcement processes. Brain Research. 436: 234-9. PMID 2829990 DOI: 10.1016/0006-8993(87)91667-2  0.585
1986 Shippenberg TS, Herz A. Differential effects of mu and kappa opioid systems on motivational processes. Nida Research Monograph. 75: 563-66. PMID 2829003  0.583
1985 Shippenberg TS, Altshuler HL. A drug discrimination analysis of ethanol-induced behavioral excitation and sedation: the role of endogenous opiate pathways. Alcohol (Fayetteville, N.Y.). 2: 197-201. PMID 4015843 DOI: 10.1016/0741-8329(85)90045-X  0.685
1982 Altshuler HL, Shippenberg TS. Tetrahydroisoquinoline and opioid substrates of alcohol actions. Progress in Clinical and Biological Research. 90: 329-44. PMID 7202207  0.694
1981 Altshuler HL, Applebaum E, Shippenberg TS. The effects of opiate antagonists on the discriminative stimulus properties of ethanol. Pharmacology, Biochemistry, and Behavior. 14: 97-100. PMID 7465612 DOI: 10.1016/0091-3057(81)90109-X  0.68
1981 Altshuler HL, Shippenberg TS. A subhuman primate model for fetal alcohol syndrome research. Neurobehavioral Toxicology and Teratology. 3: 121-6. PMID 7254459  0.656
Show low-probability matches.